These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

758 related items for PubMed ID: 15491709

  • 1. Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy.
    Gonzalez CM, Roehl KA, Antenor JV, Blunt LW, Han M, Catalona WJ.
    Urology; 2004 Oct; 64(4):723-8. PubMed ID: 15491709
    [Abstract] [Full Text] [Related]

  • 2. Chromogranin A and biochemical progression-free survival in prostate adenocarcinomas submitted to radical prostatectomy.
    Alessandro S, Vincenzo G, Maria AG, Stefano S, Alessandro G, Salvatore M, Vincenzo T, Franco DS.
    Endocr Relat Cancer; 2007 Sep; 14(3):625-32. PubMed ID: 17914093
    [Abstract] [Full Text] [Related]

  • 3. Invasion of seminal vesicles by adenocarcinoma of the prostate: PSA outcome determined by preoperative and postoperative factors.
    Bloom KD, Richie JP, Schultz D, Renshaw A, Saegaert T, D'amico AV.
    Urology; 2004 Feb; 63(2):333-6. PubMed ID: 14972484
    [Abstract] [Full Text] [Related]

  • 4. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
    Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC.
    J Urol; 2003 Feb; 169(2):517-23. PubMed ID: 12544300
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.
    Lee HM, Solan MJ, Lupinacci P, Gomella LG, Valicenti RK.
    Urology; 2004 Jul; 64(1):84-9. PubMed ID: 15245941
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Percent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigen.
    San Francisco IF, Regan MM, Olumi AF, DeWolf WC.
    J Urol; 2004 Apr; 171(4):1492-9. PubMed ID: 15017206
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort.
    Tahir SA, Frolov A, Hayes TG, Mims MP, Miles BJ, Lerner SP, Wheeler TM, Ayala G, Thompson TC, Kadmon D.
    Clin Cancer Res; 2006 Aug 15; 12(16):4872-5. PubMed ID: 16914574
    [Abstract] [Full Text] [Related]

  • 13. Outcome and complications of radical prostatectomy in patients with PSA <10 ng/ml: comparison between the retropubic, perineal and laparoscopic approach.
    Salomon L, Levrel O, Anastasiadis AG, Saint F, de La Taille A, Cicco A, Vordos D, Hoznek A, Chopin D, Abbou CC.
    Prostate Cancer Prostatic Dis; 2002 Aug 15; 5(4):285-90. PubMed ID: 12627213
    [Abstract] [Full Text] [Related]

  • 14. Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomy.
    Rogers CG, Khan MA, Craig Miller M, Veltri RW, Partin AW.
    Cancer; 2004 Dec 01; 101(11):2549-56. PubMed ID: 15470681
    [Abstract] [Full Text] [Related]

  • 15. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD, Koch MO.
    J Urol; 2005 Dec 01; 174(6):2181-5. PubMed ID: 16280760
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preoperative PSA and progression-free survival after radical prostatectomy for Stage T1c disease.
    Antenor JA, Roehl KA, Eggener SE, Kundu SD, Han M, Catalona WJ.
    Urology; 2005 Jul 01; 66(1):156-60. PubMed ID: 15992903
    [Abstract] [Full Text] [Related]

  • 18. Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer?
    van Oort IM, Schout BM, Kiemeney LA, Hulsbergen CA, Witjes JA.
    Eur Urol; 2005 Oct 01; 48(4):572-6. PubMed ID: 16046051
    [Abstract] [Full Text] [Related]

  • 19. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy.
    Ward JF, Blute ML, Slezak J, Bergstralh EJ, Zincke H.
    J Urol; 2003 Nov 01; 170(5):1872-6. PubMed ID: 14532796
    [Abstract] [Full Text] [Related]

  • 20. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U, Scattoni V, Freschi M, Briganti A, Salonia A, Gallina A, Colombo R, Karakiewicz PI, Rigatti P, Montorsi F.
    Eur Urol; 2008 Jul 01; 54(1):118-25. PubMed ID: 18314255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.